The Library

Treatment & Research reports

122 reports, newest first · page 1 of 5

2026

  1. A Mesothelioma Drug Attacks the Tumor's Own Stress Defenses. Here's What Its First Trial Actually Found
  2. Alintegimod (7HP349) Trial Adds a Mesothelioma Cohort
  3. Italian Imaging-Meso Study Maps the Mesothelioma Immune Map
  4. MDNA11 IL-2 Superkine Trial Includes Pleural Mesothelioma
  5. Rina-S Trial Adds Mesothelioma to Its Tumor Cohorts
  6. TNG462 Trial: PRMT5 Inhibitor for MTAP-Deleted Mesothelioma
  7. STEALTH-001 Trial Tests VET3-TGI in Solid Tumors
  8. VT3989 TEAD Inhibitor Trial Opens to Mesothelioma Patients
  9. The NCI's BAP1 Mesothelioma Registry Aims to Enroll 1,000
  10. South African Asbestos Miners Face Higher Mortality
  11. 3D Mesothelioma Spheroids Reveal Why Chemo Often Fails
  12. Mesothelioma Prognosis: ECOG Score Spans 4 to 14 Months
  13. HIPEC and Cytoreductive Surgery for Peritoneal Mesothelioma
  14. How to Find and Join a Mesothelioma Trial
  15. First-Line Mesothelioma Treatment: 18.1 vs. 14.1 Months
  16. Second-Line Mesothelioma Treatment: What Comes Next
  17. Mesothelioma Survival Rates by Stage and Histology
  18. Pleurectomy/Decortication vs Extrapleural Pneumonectomy
  19. Stage 1 Pleural Mesothelioma: When Surgery Is an Option
  20. Stage 2 Pleural Mesothelioma: The Borderline-Operable Case
  21. Stage 3 Pleural Mesothelioma: When Surgery Isn't an Option
  22. Mesothelioma Chest Pain: What Makes It Different
  23. Mesothelioma Early Warning Signs After Asbestos Exposure
  24. The Mesothelioma Symptom Timeline
  25. Pleural Effusion in Mesothelioma: Drainage and Recurrence
  26. Stage 4 Mesothelioma: What to Expect
  27. Two Chemo-Combo Trials, Two Very Different Signals
  28. FDA Grants Orphan Drug Status to Orion's ODM-212
  29. V Foundation Grants $1 Million for BAP1 Mesothelioma Study
  30. Louisiana Mesothelioma by the Numbers